FDA records indicate that there are no current recalls for this drug.
Are you a medical professional?
Trending Topics
Cefaclor For Suspension Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
There is currently no side effect or adverse reaction information available for this drug.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
There is current no usage information for this drug.
History
There is currently no drug history available for this drug.
Other Information
There is currently no other information available for this drug.
Sources
Cefaclor For Suspension Manufacturers
-
Fsc Laboratories, Inc.
Cefaclor For Suspension | Fsc Laboratories, Inc.
Cefaclor is administered orally.
AdultsThe usual adult dosage is 250 mg every 8 hours. For more severe infections (such as pneumonia) or those caused by less susceptible organisms, doses may be doubled.
Pediatric PatientsThe usual recommended daily dosage for pediatric patients is 20 mg/kg/day in divided doses every 8 hours. In more serious infections, otitis media, and infections caused by less susceptible organisms, 40 mg/kg/day are recommended, with a maximum dosage of 1 g/day.
Table 3: Cefaclor for Oral Suspension, USP 20 mg/kg/day Weight 125 mg/5 mL 250 mg/5 mL 9 kg 1/2 tsp t.i.d. 18 kg 1 tsp t.i.d. 1/2 tsp t.i.d. 40 mg/kg/day 9 kg 1 tsp t.i.d. 1/2 tsp t.i.d. 18 kg 1 tsp t.i.d. B.I.D. Treatment OptionFor the treatment of otitis media and pharyngitis, the total daily dosage may be divided and administered every 12 hours.
Table 4: Cefaclor for Oral Suspension, USP 20 mg/kg/day
(Pharyngitis) Weight 375 mg/5 mL 18 kg 1/2 tsp b.i.d. 40 mg/kg/day
(Otitis Media) 9 kg 1/2 tsp b.i.d. 18 kg 1 tsp b.i.d.Cefaclor may be administered in the presence of impaired renal function. Under such a condition, the dosage usually is unchanged (see PRECAUTIONS).
In the treatment of β-hemolytic streptococcal infections, a therapeutic dosage of cefaclor should be administered for at least 10 days.
Directions for MixingAdd appropriate water volume as indicated in the following table in two portions to dry mixture in the bottle. Shake well after each addition.
Each 5 mL (approximately one teaspoonful) will then contain Cefaclor, USP, monohydrate equivalent to 125 mg, 250 mg or 375 mg anhydrous cefaclor, respectively, as shown in the following table.
Oversize bottle provides extra space for shaking.
Table 5: Cefaclor For Oral Suspension, USP Strength
Package Size
(when mixed) Water Volume to Add Anhydrous Cefaclor/5 mL
(approx. one teaspoonful) 125 mg/5 mL
150 mL 106 mL 125 mg 250 mg/5 mL
150 mL 106 mL 250 mg 375 mg/5 mL
100 mL 68 mL 375 mg
Login To Your Free Account